Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boosting the Beneficial Non-specific Effects of Live Attenuated Vaccines: A Randomized Controlled Trial (RCT) of a Second Dose of Measles Vaccine (MV) in the Second Year of Life

NCT02943681 is registered in ClinicalTrials.gov with Bandim Health Project as lead sponsor.

NCT NCT02943681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boosting the Beneficial Non-specific Effects of Live Attenuated Vaccines: A Randomized Controlled Trial (RCT) of a Second Dose of Measles Vaccine (MV) in the Second Year of Life
Lead sponsor
Bandim Health Project
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2016
Completion date
May 31, 2021
Enrollment
3,812 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child morbidity, child mortality